List of Figures
Figure 1-1: Bangladesh – Per Capita Healthcare Expenditure (US$), 2015 - 2017
Figure 1-2: Bangladesh – Healthcare Expenditure (US$ Billion), 2015 - 2017
Figure 1-3: Bangladesh – Pharmaceutical Market Share by Local v/s Multinational Companies (BDT/US$ Billion), 2018
Figure 1-4: Bangladesh – Pharmaceutical Market Size (BDT/US$ Billion), 2015 - 2019
Figure 1-5: Bangladesh – Pharmaceutical Market Size (BDT/US$ Billion), 2020 - 2025
Figure 1-6: Bangladesh – Production Share of Generics & Patented Drugs (%), 2018
Figure 1-7: Bangladesh – Pharmaceutical Export Market (US$ Million), 2015 - 2019
Figure 2-1: Bangladesh – Newly Diagnosed Cancer Cases, 2018, 2020 & 2025
Figure 2-2: Bangladesh – Number of Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-3: Bangladesh – Newly Diagnosed Cancer Cases by Leading Cancer Type, 2018
Figure 2-4: Bangladesh – Newly Diagnosed Cancer Cases by Leading Cancer Type (%), 2018
Figure 2-5: Bangladesh – Cancer Related Deaths by Leading Cancer Type, 2018
Figure 2-6: Bangladesh – Cancer Related Deaths by Leading Cancer Type (%), 2018
Figure 2-7: Bangladesh – Newly Diagnosed Cancer Cases by Gender, 2018
Figure 2-8: Bangladesh – Cancer Related Deaths by Gender, 2018
Figure 2-9: Bangladesh – Newly Diagnosed Cancer Cases by Gender (%), 2018
Figure 2-10: Bangladesh – Newly Diagnosed Male Cancer Cases, 2018, 2020 & 2025
Figure 2-11: Bangladesh – Newly Diagnosed Female Cancer Cases, 2018, 2020 & 2025
Figure 2-12: Bangladesh – Male Cancer Cases by Cancer Type, 2018
Figure 2-13: Bangladesh – Female Cancer Cases by Cancer Type (%), 2018
Figure 2-14: Bangladesh – Age Standardized Incidence Rate of Leading Male Cancer (Per 100’000 People), 2018
Figure 2-15: Bangladesh – Age Standardized Incidence Rate of Leading Female Cancer (Per 100’000 People), 2018
Figure 2-16: Bangladesh – Newly Diagnosed Cancer Cases by Age, 2018
Figure 2-17: Bangladesh – Newly Diagnosed Cancer Cases by Age (%), 2018
Figure 2-18: Bangladesh – Cancer Related Deaths by Age, 2018
Figure 2-19: Bangladesh – Newly Diagnosed Cancer Cases by Age (%), 2018
Figure 2-20: Bangladesh – Oesophagus Cancer Cases, 2018, 2020 & 2025
Figure 2-21: Bangladesh – Oesophagus Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-22: Bangladesh – Age-Standardized Oesophagus Cancer Incidence & Mortality Rate (Per 100’000 People), 2018
Figure 2-23: Bangladesh – Lip,Oral Cavity Cancer Cases, 2018, 2020 & 2025
Figure 2-24: Bangladesh – Lip, Oral Cavity Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-25: Bangladesh – Age-Standardized Lip, Oral Cavity Cancer Incidence & Mortality Rate (Per 100’000 People), 2018
Figure 2-26: Bangladesh – Breast Cancer Cases, 2018, 2020 & 2025
Figure 2-27: Bangladesh – Breast Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-28: Bangladesh – Age-Standardized Breast Cancer Incidence & Mortality Rate (Per 100’000 People), 2018
Figure 2-29: Bangladesh – Lung Cancer Cases, 2018, 2020 & 2025
Figure 2-30: Bangladesh – Lung Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-31: Bangladesh – Age-Standardized Lung Cancer Incidence & Mortality Rate (Per 100’000 People), 2018
Figure 2-32: Bangladesh – Cervix Uteri Cancer Cases, 2018, 2020 & 2025
Figure 2-33: Bangladesh – Cervix Uteri Cancer Related Deaths, 2018, 2020 & 2025
Figure 2-34: Bangladesh – Age-Standardized Cervix Uteri Cancer Incidence & Mortality Rate (Per 100’000 People), 2018
Figure 3-1: Bangladesh - Adult Diabetic Population (Million), 2010 & 2019
Figure 3-2: Bangladesh - Estimated Number of Adult Diabetic Population (Million), 2030 & 2045
Figure 3-3: Bangladesh - Diagnosed v/s Undiagnosed Adult Diabetic Population (Million), 2019
Figure 3-4: Bangladesh - Diagnosed v/s Undiagnosed Adult Diabetic Population Share (%), 2019
Figure 3-5: Bangladesh - Age Adjusted Diabetes Prevalence Rate (%), 2019, 2030 & 2045
Figure 3-6: Bangladesh - Diabetes Related Deaths, 2010 & 2019
Figure 3-7: Bangladesh - Population Estimates (Million), 2019, 2020, 2025 & 2030
Figure 3-8: Bangladesh - Adult Diabetes Cases by Type (Million), 2019
Figure 3-9: Bangladesh - Diabetes Cases by Type (%), 2019
Figure 3-10: Bangladesh - Type 1 Diabetic Adult Population (Million), 2019, 2025 & 2045
Figure 3-11: Bangladesh - Total & Newly Diagnosed Type 1 Diabetic Cases in Age below 19 Years, 2019
Figure 3-12: Bangladesh – Type 2 Diabetic Population (Million), 2019, 2030 & 2045
Figure 3-13: Bangladesh - Diabetes Prevalence Rate by Gender (%), 2016
Figure 3-14: Bangladesh - Newly Diagnosed Type 1 Diabetes Cases in Children by Age, 2019
Figure 3-15: Bangladesh - Type 1 Diabetes Cases in Children by Age, 2019
Figure 3-16: Bangladesh - Type 1 Diabetes Cases in Children by Age (%), 2019
Figure 3-17: Bangladesh - Obesity Prevalence Rate by Gender (%), 2019
Figure 3-18: Bangladesh - Obese Population v/s Total Population (Million), 2020
Figure 4-1: Bangladesh – Total HIV Cases & Newly Diagnosed HIV Cases, 2018
Figure 4-2: Bangladesh – HIV Cases, 2010, 2015 & 2018
Figure 4-3: Bangladesh – New Diagnosed HIV Cases, 2010, 2015 & 2018
Figure 4-4: Bangladesh – New Diagnosed HIV Cases by Gender, 2018
Figure 4-5: Bangladesh - New Diagnosed HIV Cases by Gender (%), 2018
Figure 4-6: Bangladesh – Total HIV Cases by Age & Gender, 2018
Figure 4-7: Bangladesh – Number of HIV Patients by Known Status & ART Therapy, 2018
Figure 4-8: Bangladesh – Number of HIV Patients by Known Status & ART Therapy (%), 2018
Figure 4-9: Bangladesh – Share of ART Receiving Patients In Total HIV Patients (%), 2015 - 2018
Figure 4-10: Bangladesh – Number of ART Receiving Patients by Gender, 2018
Figure 4-11: Bangladesh – Number of ART Receiving Patients by Gender (%), 2018
Figure 4-12: Bangladesh – ART Receiving Patients by Age, 2018
Figure 4-13: Bangladesh – Patients with Late HIV Diagnosis by CD4 Cell Count (%), 2018
Figure 5-1: Bangladesh – Known & Unknown Hepatitis-B Infection Cases (%), 2018
Figure 5-2: Bangladesh – Risk of Developing other Liver Complication due to Hepatitis-B (%), 2018
Figure 5-3: Bangladesh – Number of Children Born with Hepatitis-B Infection (%), 2018
Figure 5-4: Bangladesh – Number of Diarrhea Related Deaths (Per 1 Million People), 2003, 2013 & 2018
Figure 5-5: Bangladesh – Diarrhea Cases by Causative Microorganism, 2018
Figure 5-6: Bangladesh – Diarrhea Related Deaths v/s Others, 2018
Figure 5-7: Bangladesh – New/Relapsed Tuberculosis Cases & Deaths by Type, 2018
Figure 5-8: Bangladesh – Estimated Tuberculosis Incidence Rate by Type, 2018
Figure 5-9: Bangladesh – New & Relapsed TB Cases v/s Number of Estimated TB Cases, 2018
Figure 5-10: Bangladesh – New & Relapsed TB Cases by Gender & Age, 2018
Figure 5-11: Bangladesh – Adult TB Cases by Gender, 2018
Figure 5-12: Bangladesh – Pneumonia Related Deaths in Age less than 5 Years, 2018
Figure 5-13: Bangladesh – Pneumonia Related Deaths in Age less than 5 Years (%), 2018
Figure 6-1: Bangladesh – Total Population v/s Population with Hypertension (Million), 2020
Figure 6-2: Bangladesh – Share of Hypertensive Patient (%), 2020
Figure 6-3: Bangladesh – Hypertensive Population by Status (Million), 2020
Figure 6-4: Bangladesh – Hypertensive Population by Status (Million), 2020
Figure 6-5: Bangladesh – Hypertensive Prevalence in Urban & Rural Area (%), 2017
Figure 6-6: Bangladesh – Hypertensive Prevalence by Gender (%), 2017
Figure 6-7: Bangladesh – Hypertensive Prevalence by Age (%), 2017
Figure 6-8: Bangladesh – Number of Coronary Heart Disease & Stroke Related Deaths, 2018
Figure 6-9: Bangladesh –Coronary Heart Disease & Stroke Related Deaths v/s Deaths Related to Other Complications, 2018
Figure 6-10: Bangladesh – Age adjusted Death Rate of Coronary Heart Disease & Stroke (Per 100’000), 2018
Figure 7-1: Bangladesh – Generic Pharmaceutical Market Size (BDT/US$ Billion), 2016 - 2019
Figure 7-2: Bangladesh – Generic Pharmaceutical Market Size (BDT/US$ Billion), 2020 - 2025
Figure 7-3: Bangladesh – Top 10 Generic Pharmaceutical Company by Market Share (%), 2017
Figure 7-4: Bangladesh – Top 10 Generic Pharmaceutical Company by Market Share (%), 2017
Figure 7-5: Bangladesh – Patented Pharmaceutical Market Size (BDT/US$ Billion), 2020 - 2025
Figure 7-6: Bangladesh – Number of Registered Allopathic Manufacturers, Drugs, Generics & Retail Pharmacies, 2018
Figure 7-7: Bangladesh – Number of Registered Homeopathic Manufacturers, Drugs & Retail Pharmacies, 2018
Figure 7-8: Bangladesh – Number of Registered Unani Manufacturers, Drugs & Retail Pharmacies, 2018
Figure 7-9: Bangladesh – Number of Registered Ayurvedic Manufacturers, Drugs & Retail Pharmacies, 2018
Figure 7-10: Bangladesh – Local Pharmaceutical Market Size (BDT/US$ Billion), 2015 - 2018
Figure 7-11: Bangladesh – Pharmaceutical Market Size of Multinational Companies (BDT/US$ Billion), 2015 - 2018
Figure 7-12: Bangladesh – Pharmaceutical Market Size by Type of Companies (BDT/US$ Billion), 2025
Figure 7-13: Bangladesh – Share of Leading Local Pharma Company in Total Pharmaceutical Market (%), Q2 2017
Figure 7-14: Bangladesh – Share of Leading MNCs Pharma Company in Total Pharmaceutical Market (%), Q2 2017
Figure 7-15: Bangladesh – Pharmaceutical Market Size by Therapeutic Class (BDT/US$ Billion), 2018
Figure 7-16: Bangladesh – Year over Year Growth Rate by Therapeutic Segment (%), 2018
Figure 7-17: Bangladesh – Share of Gastroenterological Class in Total Pharma Market (%), 2015 - 2018
Figure 7-18: Bangladesh – Share of Anti-Infectives in Total Pharma Market (%), 2015 - 2018
Figure 7-19: Bangladesh – Share of Pain Killers in Total Pharma Market (%), 2015 - 2018
Figure 7-20: Bangladesh – Pharmaceutical Export Market (US$ Million), 2019 - 2025
Figure 7-21: Bangladesh – Pharmaceutical Export & Import Market (US$ Million), 2019
Figure 7-22: Bangladesh – Share of Imported API in Total API Consumption (%), 2019
Figure 7-23: Bangladesh – Pharmaceutical Export Earnings by Countries (US$ Million), 9 Month’2019
Figure 7-24: Bangladesh – Bxpharma Pharmaceutical Export Earnings (BDT/US$ Million), 2016 - 2018
Figure 7-25: Bangladesh – Square Pharmaceutical Export Earnings (BDT/US$ Million), 2016 - 2018
Figure 7-26: Bangladesh – Ranata Pharmaceutical Export Earnings (BDT/US$ Million), 2016 - 2018
Figure 7-27: Bangladesh – ACME Pharmaceutical Export Earnings (BDT/US$ Million), 2016 - 2018
Figure 8-1: Seclo – Price for 120 Capsules, 5 Capsules & Price per Unit capsule of 20mg (BDT/US$), July’2020
Figure 8-2: Seclo – Price for 120 Capsules, 5 Capsules & Price per Unit capsule of 40mg (BDT/US$), July’2020
Figure 8-3: Seclo – Recommended Oral Dose by Indication (mg/day), July’2020
Figure 8-4: Seclo – Recommended IV Dose by Indication (mg/day), July’2020
Figure 8-5: Sergel – Price for 100 Capsules & Price per Unit Capsule of 20mg (BDT/US$), July’2020
Figure 8-6: Sergel – Price for 50 Capsules & Price per Unit Capsule of 40mg (BDT/US$), July’2020
Figure 8-7: Sergel – Price for 30 Tablets & Price per Unit Tablet of 20mg (BDT/US$), July’2020
Figure 8-8: Seclo – Price for 30 Tablets & Price per Unit Tablet of 40mg (BDT/US$), July’2020
Figure 8-9: Sergel – Recommended Adult & Pediatric Dose (mg/day)
Figure 8-10: Maxpro – Price for 140 Tablet & Price per Unit Tablet of 20mg (BDT/US$), July’2020
Figure 8-11: Maxpro – Price for 5 Tablet & Price per Unit Tablet of 20mg (BDT/US$), July’2020
Figure 8-12: Maxpro – Price for 40 Tablet & Price per Unit Tablet of 40mg (BDT/US$), July’2020
Figure 8-13: Maxpro – Price for 10 Tablet & Price per Unit Tablet of 40mg (BDT/US$), July’2020
Figure 8-14: Maxpro – Price for 100 Capsules, 14 Capsules & Price per Unit Capsule of 20mg (BDT/US$), July’2020
Figure 8-15: Maxpro – Price for 60 Capsules & Price per Unit Capsule of 40mg (BDT/US$), July’2020
Figure 8-16: Sergel – Recommended Adult & Pediatric Dose (mg/day)
Figure 8-17: Pantonix – Price for 70 Tablet & Price per Unit Tablet of 20mg (BDT/US$), July’2020
Figure 8-18: Pantonix – Price for 14 Tablet & Price per Unit Tablet of 20mg (BDT/US$), July’2020
Figure 8-19: Pantonix – Price for 70 Tablet & Price per Unit Tablet of 40mg (BDT/US$), July’2020
Figure 8-20: Pantonix – Price for 14 Tablet & Price per Unit Tablet of 40mg (BDT/US$), July’2020
Figure 8-21: Pantonix – Recommended Minimum & Maximum Oral Dose (mg/day)
Figure 8-22: Pantonix – Minimum & Maximum Duration of Oral Therapy (Weeks)
Figure 8-23: Pantonix – Recommended Minimum & Maximum Intravenous Dose (mg/day)
Figure 8-24: Cef-3 – Price for 14 Capsule & Price per Unit Capsule of 200mg (BDT/US$), July’2020
Figure 8-25: Cef-3 – Price for 6 Capsules, 12 Capsules & Price per Unit Capsule of 400mg (BDT/US$), July’2020
Figure 8-26: Cef-3 Suspension – Price for 30ml, 50ml & 75ml Suspension of Dose 100mg/5ml (BDT/US$), July’2020
Figure 8-27: Cef-3 Suspension – Price for 50ml Supply & Price per ml of 200mg/5ml Suspension (BDT/US$), July’2020
Figure 8-28: Cef-3 Pediatric Drops – Price for 21ml Supply & Price per ml of 25mg/ml Drops (BDT/US$), July’2020
Figure 8-29: Cef-3 – Recommended Minimum & Maximum Dose for Gonorrhea (mg/day)
Figure 8-30: Cef-3 – Usual Adult & Pediatric Dose (mg/day)
Figure 8-31: Mixtard 30 – Price for 10ml & Price per ml of 40IU/ml Vial (BDT/US$), July’2020
Figure 8-32: Mixtard 30 – Price for 10ml & Price per ml of 100 IU/ml Vial (BDT/US$), July’2020
Figure 8-33: Mixtard 30 – Price for 5 Penfill Supply & Price for Single Penfill of 100 IU/ml Vial (BDT/US$), July’2020
Figure 8-34: Mixtard 30 – Price for 5 Flexpen Supply & Price for Single Flexpen of 100 IU/ml Vial (BDT/US$), July’2020
Figure 8-35: Mixtard 30 – Recommended Minimum & Maximum Dose for Type 1 Diabetes (IU/Kg/Day), July’2020
Figure 8-36: Mixtard 30 – Recommended Minimum & Maximum Dose for Type 2 Diabetes (IU/Kg/Day), July’2020
Figure 8-37: Napa Extra – Price for 240 Tablets & Price per Unit Tablet (BDT/US$), July’2020
Figure 8-38: Napa Extra – Price for 12 Tablets & Price per Unit Tablet (BDT/US$), July’2020
Figure 8-39: Napa Extra – Minimum & Maximum Cost of Daily Treatment (BDT/US$), July’2020
Figure 8-40: Losectill – Price for 40 Capsules & Price per Unit Capsule of 10mg (BDT/US$), July’2020
Figure 8-41: Losectill – Price for 100, 120 & 500 Capsules of 20mg (BDT/US$), July’2020
Figure 8-42: Losectill – Price for 60 Capsules & Price per Unit Capsule of 40mg (BDT/US$), July’2020
Figure 8-43: Losectill – Price for 50 Sachets & Price for Single Sachet of 20mg (BDT/US$), July’2020
Figure 8-44: Losectill – Price for 30 Sachets & Price for Single Sachet of 20mg (BDT/US$), July’2020
Figure 8-45: Losectil – Recommended Minimum & Maximum Oral Dose (mg/day), July’2020
Figure 8-46: Losectil – Recommended Minimum & Maximum IV Dose (mg/day), July’2020
Figure 8-47: Napa – Price for 500 Tablet Supply & 10 Tablet Supply of 500mg (BDT/US$), July’2020
Figure 8-48: Napa – Price for 200 Tablet Supply & Price per unit Tablet of 1000mg (BDT/US$), July’2020
Figure 8-49: Napa Suspension – Price for 50ml Supply & 60ml Supply of 120mg/5ml Suspension (BDT/US$), July’2020
Figure 8-50: Napa Syrup – Price for 50ml, 60ml & 100ml Supply of 120mg/5ml Syrup (BDT/US$), July’2020
Figure 8-51: Napa Pediatric Drops – Price for 15ml Supply & Price per unit ml of 80mg/ml Drops (BDT/US$), July’2020
Figure 8-52: Napa Suppositories – Price for 20 Suppositories of various Dose Regimen (BDT/US$), July’2020
Figure 8-53: Napa IV Solution – Price for 100ml Supply & Price per unit ml of Intravenous Solution (BDT/US$), July’2020
Figure 8-54: Napa Tablet – Minimum & Maximum Recommended Adult Dose (gm/day), July’2020
Figure 8-55: Napa Tablet – Pediatric Dose by Age (mg/ 4 Times a day), July’2020
Figure 8-56: Exium – Price for 100 Capsules Supply & Price per unit Capsule of 20mg (BDT/US$), July’2020
Figure 8-57: Exium – Price for 60 Capsules Supply & Price per unit Capsule of 40mg (BDT/US$), July’2020
Figure 8-58: Exium – Price for 56 Tablets Supply & Price per unit MUPS Tablet of 20mg (BDT/US$), July’2020
Figure 8-59: Exium – Price for 28 Tablets Supply & Price per unit MUPS Tablet of 40mg (BDT/US$), July’2020
Figure 8-60: Exium – Minimum & Maximum Recommended Adult Dose (mg/day), July’2020
Figure 8-61: Exium – Minimum & Maximum Recommended Pediatric Dose (mg/day), July’2020
Figure 9-1: Bangladesh – Number of Clinical Trials by Phase, June’2020
Figure 9-2: Bangladesh – Clinical Trials by Phase (%), June’2020
Figure 9-3: Bangladesh – Number of Clinical Trials by Status, June’2020
Figure 9-4: Bangladesh – Clinical Trials by Status (%), June’2020
Figure 9-5: Bangladesh – Number of Clinical Trials by Infectious & Non Infectious Diseases (%), June’2020
Figure 9-6: Bangladesh – Number of Clinical Trials by Indications, June’2020
Figure 9-7: Bangladesh – Clinical Trials by Indication (%), June’2020
Figure 10-1: Bangladesh Pharmaceutical Market Drivers
Figure 10-2: Challenges for Bangladesh Pharmaceutical Market
